Get research updatesPublic study records, presented in a clearer and more patient-friendly format for mental health research discovery.
A Phase 3, Randomized, Double-blind, Placebo-controlled Trial of Solriamfetol in Adults With ADHD.
This study has finished and is no longer accepting participants.
Multiple locations, including EncinoA Phase 2, Multicenter, Double-blind, Randomized, Placebo-controlled Trial to Assess the Efficacy, Safety, and Tolerability of Repeated Doses of VLS-01 Buccal Film in Participants With Treatment Resistant Depression
This study has finished and is no longer accepting participants.
Multiple locations, including TucsonA Randomized, Placebo-Controlled, Double-Blinded, Phase 2 Study to Evaluate the Efficacy, Safety, and Tolerability of Oral NORA520 in Female Adults With Severe Postpartum Depression
This study has finished and is no longer accepting participants.
Multiple locations, including BentonvilleResearchers are comparing Solriamfetol and placebo, tracking side effects to assess long-term safety in adults with binge eating.
This study is by invitation only.
Multiple locations, including EncinoA Phase 1, Open-label, Cross-over Study in Healthy Volunteers to Assess the Pharmacokinetic Profile of Prazosin and Cyproheptadine Following Single Dose Oral Administration of KT110 Tablet and Following Administration of Alpress and Periactin Marketed Tablets
This study has finished and is no longer accepting participants.
In GièresA Single-Dose, Open-Label, Randomized, Parallel-Group Study to Assess the Pharmacokinetics, Safety, and Tolerability of a Paliperidone Palmitate 3-Month Formulation in Subjects With Schizophrenia
This study has finished and is no longer accepting participants.
Multiple locations, including Little RockA Phase 1, Single-centre, Double-blind, Placebocontrolled Crossover Study to Assess the pharmacoMRI Effects of AUT00206 in Healthy Male Participants
This study has finished and is no longer accepting participants.
In London
A Retrospective, Observational Study to Assess the Rate of Hospitalization in Patients With Schizophrenia Treated One Year Before With Oral Antipsychotics and One Year After With Long Acting Injectable Atypical Antipsychotics - REALAI Study
This study has finished and is no longer accepting participants.
Multiple locations, including AracajuA Phase 1, Cross-Over, Single-Dose, Open-Label Study to Estimate the Relative Bioavailability of a Modified-Release Formulation of PF-05180999 Under Fed and Fasted Conditions in Healthy Adult Subjects
This study has finished and is no longer accepting participants.
In New HavenAssessment of Safe-use Conditions for Administration of ZULRESSO in a Home Setting
This study has finished and is no longer accepting participants.
Multiple locations, including Culver CityThis study evaluated the safety and effectiveness of ASP4345 for people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including CerritosA Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of ASP8062 as an Add-on Therapy to Buprenorphine/Naloxone in Participants With Opioid Use Disorder
This study was withdrawn before enrollment.
Location not clearly listedWe gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.